Your Article Summary
See Latest ArticlesPharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers
Antimicrobial Agents and Chemotherapy, 06/30/09
Ashley ESD et al. - Oral and nasogastric tube administration of a single 400-mg dose of posaconazole suspension was safe and well tolerated in healthy adult subjects. The incidence and nature of treatment-emergent adverse events were similar with both administration routes, and no serious adverse events or clinically significant laboratory test or vital sign abnormalities were reported.
Related Articles
Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment
Current Medical Research and Opinion, 11/06/09
Relevance Score: 88%
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
Bone Marrow Transplantation, 10/07/09
Relevance Score: 88%
Mueller–Hinton methylene blue media as an alternative to RPMI 1640 for determining the susceptibility of Cryptococcus neoformans and Cryptococcus gattii to posaconazole with Etest
Mycoses, 10/28/09
Relevance Score: 84%
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Antimicrobial Agents and Chemotherapy, 11/20/09
Relevance Score: 83%
Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers
Antimicrobial Agents and Chemotherapy, 10/21/09
Relevance Score: 83%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
Intensive Care Medicine, 12/09/09
Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09